A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Clinical trial NCT00048126 · COMPLETED
Trial details
- NCT number
- NCT00048126
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Primary completion
- 2005-01-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.